IRS Grants Tech, Pharma a Tax Break Boost From Trump Deduction

IRS Grants Tech, Pharma a Tax Break Boost From Trump Deduction

The Internal Revenue Service has handed a significant tax break to large corporations, ensuring that a lucrative research and development deduction doesn’t inadvertently increase their tax bills under a separate 15% minimum levy. The agency issued interim guidance allowing companies to claim a backlog of R&D deductions stretching back to 2022, which helps minimize their exposure to the corporate alternative minimum tax.

This new guidance doesn’t completely shield companies from the minimum tax, but it does allow them to reduce their overall tax burden. They can now subtract old domestic R&D investments from the income used to calculate their liability. This decision is a major victory for research-intensive industries like technology, pharmaceuticals, and manufacturing.

Without this ruling, some companies discovered that the retroactive tax break was so generous it actually triggered the corporate alternative minimum tax, which applies to businesses with at least $1 billion in annual profits. A trade association for manufacturers praised the decision, stating it would “supercharge” private sector investment in research.

However, the move was quickly criticized by some lawmakers, who had warned against issuing the guidance. They argued that the limitations the minimum tax placed on the retroactive break showed the tax was working as intended to ensure large companies pay their share. They accused the IRS of ignoring the tax code to benefit those at the top.

The official guidance serves as a notice of how the agency plans to enforce the law, though a future administration could change it. The ruling stems from a recent reversal of a requirement that R&D deductions be spread out over five years. That change also allowed companies to deduct any unclaimed breaks dating back to 2022.

This backlog of deductions was estimated to be worth tens of billions of dollars. The new guidelines allow a business to minimize its tax burden by subtracting these newly claimed R&D deductions from its taxable income. The guidance also permits companies to take other immediate deductions for expenses like repairs, maintenance, and production costs under the minimum tax regime.